Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$6.8 - $14.23 $103,298 - $216,167
-15,191 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$13.42 - $23.38 $10,910 - $19,007
813 Added 5.65%
15,191 $210,000
Q4 2021

Feb 07, 2022

BUY
$12.78 - $23.74 $183,750 - $341,333
14,378 New
14,378 $336,000
Q2 2020

Aug 06, 2020

SELL
$11.79 - $15.97 $131,882 - $178,640
-11,186 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$9.31 - $21.24 $21,385 - $48,788
2,297 Added 25.84%
11,186 $150,000
Q4 2019

Feb 05, 2020

BUY
$13.91 - $21.48 $123,645 - $190,935
8,889 New
8,889 $174,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.